Four years ago, my colleague and management team member here at BBK Worldwide, Rob Laurens, wrote the blog post, “How a Poster Enrolled my Clinical Trial.” I re-read it recently and thought it would be fun to look back on this article to see how our ideas about patient engagement and enrollment may have changed over the last few years thanks to technology and the rise of mHealth.
At last, patient centricity is much more than an industry buzzword. We’re seeing real efforts to put patients at the center of clinical research, and it’s beginning to impact all areas across the clinical research continuum.
On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of George Clinical - CRO China as our guest contributor. With more than 20 years of experience in pharmaceutical, biotech and medical device marketing, Mr. Gregory has spent over 14 years supporting the expansion of clinical trial capabilities in Asia. He will be providing his insights over the course of a three-part blog series on the growth of clinical research across the Asia Pacific region.
Partnering with advocacy groups is a vital component to any clinical trial outreach effort. The approach to working with advocacy groups has changed in recent years. It is not just about the one connection you may have with one organization. These days it’s about working with the condition community as a whole for one common goal. Advocacy groups often have direct connections to people affected by a condition and can be highly beneficial to enrollment throughout the patient recruitment process.
Pew Research Center indicates that 87 percent of Americans are using the Internet regularly. With social and digital media becoming ever-more prevalent, it makes sense that within the clinical trial industry, researchers are now looking to it as a way to control some of the escalating R&D costs and make the process more patient-centric.
We know that social media usage is up year-over-year across all ages, but how is it being put to use for clinical research? On June 11th I had the pleasure of participating in a social media forum hosted by MassBio with PatientsLikeMe, Biogen and Boston Children’s Hospital. It was an eye opening discussion that looked at the use of social media within clinical trials from the varying perspectives of advocacy groups, IRBs and pharmaceutical companies, each with different goals in mind and facing their own set of unique challenges.
Mobile app technology is quickly becoming the baseline in clinical trials as new innovations continue to be introduced into the market. MCT-Congress, which I recently attended in Edinburgh, is dedicated to the business of mobile technology in the clinical trial space so as you can imagine, there was much discussion around how mHealth is impacting clinical trials – from patient recruitment and enrollment to site and patient engagement throughout the trial.
Members of the BBK Worldwide team periodically attend industry events throughout the year. We love to network and learn from our peers, and when we are invited to speak we jump at the opportunity to bring our own expertise to the table and join in the conversation.
The 2015 annual SCOPE Summit for Clinical Ops Executives was a tremendous success. It was great to see some of the clinical trial industry’s elite presenting on some amazing initiatives to raise awareness of clinical research. In thinking about all of the collaborative discussions that took place at the conference this year (and there were many), the following are three key takeaways that represent an exciting future for patient centricity within the clinical research industry.
According to industry estimates reported by research2guidance, 500 million smartphone users worldwide will be using a healthcare app this year, and by 2018, 50 percent of the more than 3.4 billion smartphone and tablet users will have downloaded at least one mobile health app. While patient engagement is key to the overall success of the mHealth movement, the vital role physician engagement plays must not be overlooked.